nodes	percent_of_prediction	percent_of_DWPC	metapath
Flucloxacillin—CYP3A4—bone cancer	0.955	1	CbGaD
Flucloxacillin—Reaction gastrointestinal—Methotrexate—bone cancer	0.00144	0.0326	CcSEcCtD
Flucloxacillin—Erythema nodosum—Epirubicin—bone cancer	0.00104	0.0235	CcSEcCtD
Flucloxacillin—Appetite absent—Methotrexate—bone cancer	0.000966	0.0218	CcSEcCtD
Flucloxacillin—Erythema nodosum—Doxorubicin—bone cancer	0.000962	0.0218	CcSEcCtD
Flucloxacillin—Body temperature increased—Carboplatin—bone cancer	0.000842	0.019	CcSEcCtD
Flucloxacillin—Oral candidiasis—Epirubicin—bone cancer	0.000708	0.016	CcSEcCtD
Flucloxacillin—Haemolytic anaemia—Cisplatin—bone cancer	0.000704	0.0159	CcSEcCtD
Flucloxacillin—Oral candidiasis—Doxorubicin—bone cancer	0.000655	0.0148	CcSEcCtD
Flucloxacillin—Jaundice cholestatic—Epirubicin—bone cancer	0.000512	0.0116	CcSEcCtD
Flucloxacillin—Renal failure—Cisplatin—bone cancer	0.000482	0.0109	CcSEcCtD
Flucloxacillin—Jaundice cholestatic—Doxorubicin—bone cancer	0.000474	0.0107	CcSEcCtD
Flucloxacillin—Hepatobiliary disease—Cisplatin—bone cancer	0.000463	0.0105	CcSEcCtD
Flucloxacillin—Urinary tract disorder—Cisplatin—bone cancer	0.000434	0.00982	CcSEcCtD
Flucloxacillin—Connective tissue disorder—Cisplatin—bone cancer	0.000432	0.00977	CcSEcCtD
Flucloxacillin—Colitis—Epirubicin—bone cancer	0.000432	0.00976	CcSEcCtD
Flucloxacillin—Urethral disorder—Cisplatin—bone cancer	0.000431	0.00975	CcSEcCtD
Flucloxacillin—Candida infection—Epirubicin—bone cancer	0.000429	0.00971	CcSEcCtD
Flucloxacillin—Colitis—Doxorubicin—bone cancer	0.0004	0.00903	CcSEcCtD
Flucloxacillin—Candida infection—Doxorubicin—bone cancer	0.000397	0.00898	CcSEcCtD
Flucloxacillin—Immune system disorder—Cisplatin—bone cancer	0.000397	0.00898	CcSEcCtD
Flucloxacillin—Vascular purpura—Epirubicin—bone cancer	0.000365	0.00825	CcSEcCtD
Flucloxacillin—Ill-defined disorder—Cisplatin—bone cancer	0.000355	0.00803	CcSEcCtD
Flucloxacillin—Anaemia—Cisplatin—bone cancer	0.000354	0.008	CcSEcCtD
Flucloxacillin—Malaise—Cisplatin—bone cancer	0.000345	0.00781	CcSEcCtD
Flucloxacillin—Leukopenia—Cisplatin—bone cancer	0.000343	0.00775	CcSEcCtD
Flucloxacillin—Purpura—Epirubicin—bone cancer	0.000339	0.00766	CcSEcCtD
Flucloxacillin—Vascular purpura—Doxorubicin—bone cancer	0.000338	0.00764	CcSEcCtD
Flucloxacillin—Convulsion—Cisplatin—bone cancer	0.000332	0.0075	CcSEcCtD
Flucloxacillin—Myalgia—Cisplatin—bone cancer	0.000326	0.00737	CcSEcCtD
Flucloxacillin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.000324	0.00732	CcSEcCtD
Flucloxacillin—Discomfort—Cisplatin—bone cancer	0.000322	0.00728	CcSEcCtD
Flucloxacillin—Toxic epidermal necrolysis—Methotrexate—bone cancer	0.000314	0.0071	CcSEcCtD
Flucloxacillin—Purpura—Doxorubicin—bone cancer	0.000313	0.00709	CcSEcCtD
Flucloxacillin—Anaphylactic shock—Cisplatin—bone cancer	0.000312	0.00707	CcSEcCtD
Flucloxacillin—Nervous system disorder—Cisplatin—bone cancer	0.000306	0.00693	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Cisplatin—bone cancer	0.000306	0.00692	CcSEcCtD
Flucloxacillin—Skin disorder—Cisplatin—bone cancer	0.000304	0.00686	CcSEcCtD
Flucloxacillin—Eosinophilia—Methotrexate—bone cancer	0.000299	0.00675	CcSEcCtD
Flucloxacillin—Toxic epidermal necrolysis—Epirubicin—bone cancer	0.000294	0.00665	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000285	0.00644	CcSEcCtD
Flucloxacillin—Neutropenia—Methotrexate—bone cancer	0.000282	0.00638	CcSEcCtD
Flucloxacillin—Eosinophilia—Epirubicin—bone cancer	0.000279	0.00632	CcSEcCtD
Flucloxacillin—Toxic epidermal necrolysis—Doxorubicin—bone cancer	0.000272	0.00615	CcSEcCtD
Flucloxacillin—Decreased appetite—Cisplatin—bone cancer	0.000272	0.00614	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Cisplatin—bone cancer	0.00027	0.0061	CcSEcCtD
Flucloxacillin—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.000267	0.00603	CcSEcCtD
Flucloxacillin—Renal failure—Methotrexate—bone cancer	0.000264	0.00598	CcSEcCtD
Flucloxacillin—Neutropenia—Epirubicin—bone cancer	0.000264	0.00597	CcSEcCtD
Flucloxacillin—Eosinophilia—Doxorubicin—bone cancer	0.000259	0.00585	CcSEcCtD
Flucloxacillin—Feeling abnormal—Cisplatin—bone cancer	0.000257	0.00582	CcSEcCtD
Flucloxacillin—Haematuria—Methotrexate—bone cancer	0.000256	0.0058	CcSEcCtD
Flucloxacillin—Hepatobiliary disease—Methotrexate—bone cancer	0.000254	0.00575	CcSEcCtD
Flucloxacillin—Agranulocytosis—Methotrexate—bone cancer	0.000251	0.00567	CcSEcCtD
Flucloxacillin—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.000249	0.00564	CcSEcCtD
Flucloxacillin—Renal failure—Epirubicin—bone cancer	0.000247	0.00559	CcSEcCtD
Flucloxacillin—Body temperature increased—Cisplatin—bone cancer	0.000247	0.00559	CcSEcCtD
Flucloxacillin—Jaundice—Epirubicin—bone cancer	0.000245	0.00555	CcSEcCtD
Flucloxacillin—Neutropenia—Doxorubicin—bone cancer	0.000244	0.00552	CcSEcCtD
Flucloxacillin—Hepatitis—Methotrexate—bone cancer	0.000241	0.00546	CcSEcCtD
Flucloxacillin—Haematuria—Epirubicin—bone cancer	0.00024	0.00542	CcSEcCtD
Flucloxacillin—Urinary tract disorder—Methotrexate—bone cancer	0.000238	0.00539	CcSEcCtD
Flucloxacillin—Hepatobiliary disease—Epirubicin—bone cancer	0.000238	0.00538	CcSEcCtD
Flucloxacillin—Urethral disorder—Methotrexate—bone cancer	0.000237	0.00535	CcSEcCtD
Flucloxacillin—Agranulocytosis—Epirubicin—bone cancer	0.000235	0.00531	CcSEcCtD
Flucloxacillin—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.000231	0.00522	CcSEcCtD
Flucloxacillin—Hypersensitivity—Cisplatin—bone cancer	0.00023	0.00521	CcSEcCtD
Flucloxacillin—Renal failure—Doxorubicin—bone cancer	0.000229	0.00517	CcSEcCtD
Flucloxacillin—Erythema multiforme—Methotrexate—bone cancer	0.000228	0.00516	CcSEcCtD
Flucloxacillin—Jaundice—Doxorubicin—bone cancer	0.000227	0.00513	CcSEcCtD
Flucloxacillin—Hepatitis—Epirubicin—bone cancer	0.000226	0.00511	CcSEcCtD
Flucloxacillin—Urinary tract disorder—Epirubicin—bone cancer	0.000223	0.00504	CcSEcCtD
Flucloxacillin—Haematuria—Doxorubicin—bone cancer	0.000222	0.00502	CcSEcCtD
Flucloxacillin—Connective tissue disorder—Epirubicin—bone cancer	0.000222	0.00502	CcSEcCtD
Flucloxacillin—Urethral disorder—Epirubicin—bone cancer	0.000221	0.00501	CcSEcCtD
Flucloxacillin—Hepatobiliary disease—Doxorubicin—bone cancer	0.00022	0.00498	CcSEcCtD
Flucloxacillin—Immune system disorder—Methotrexate—bone cancer	0.000218	0.00493	CcSEcCtD
Flucloxacillin—Agranulocytosis—Doxorubicin—bone cancer	0.000217	0.00491	CcSEcCtD
Flucloxacillin—Diarrhoea—Cisplatin—bone cancer	0.000214	0.00483	CcSEcCtD
Flucloxacillin—Erythema multiforme—Epirubicin—bone cancer	0.000214	0.00483	CcSEcCtD
Flucloxacillin—Hepatitis—Doxorubicin—bone cancer	0.000209	0.00473	CcSEcCtD
Flucloxacillin—Urinary tract disorder—Doxorubicin—bone cancer	0.000206	0.00467	CcSEcCtD
Flucloxacillin—Dysgeusia—Methotrexate—bone cancer	0.000206	0.00465	CcSEcCtD
Flucloxacillin—Connective tissue disorder—Doxorubicin—bone cancer	0.000205	0.00464	CcSEcCtD
Flucloxacillin—Urethral disorder—Doxorubicin—bone cancer	0.000205	0.00463	CcSEcCtD
Flucloxacillin—Immune system disorder—Epirubicin—bone cancer	0.000204	0.00461	CcSEcCtD
Flucloxacillin—Vomiting—Cisplatin—bone cancer	0.000199	0.00449	CcSEcCtD
Flucloxacillin—Erythema multiforme—Doxorubicin—bone cancer	0.000198	0.00447	CcSEcCtD
Flucloxacillin—Rash—Cisplatin—bone cancer	0.000197	0.00445	CcSEcCtD
Flucloxacillin—Dermatitis—Cisplatin—bone cancer	0.000197	0.00445	CcSEcCtD
Flucloxacillin—Ill-defined disorder—Methotrexate—bone cancer	0.000195	0.00441	CcSEcCtD
Flucloxacillin—Anaemia—Methotrexate—bone cancer	0.000194	0.00439	CcSEcCtD
Flucloxacillin—Dysgeusia—Epirubicin—bone cancer	0.000193	0.00435	CcSEcCtD
Flucloxacillin—Malaise—Methotrexate—bone cancer	0.000189	0.00428	CcSEcCtD
Flucloxacillin—Immune system disorder—Doxorubicin—bone cancer	0.000189	0.00427	CcSEcCtD
Flucloxacillin—Leukopenia—Methotrexate—bone cancer	0.000188	0.00425	CcSEcCtD
Flucloxacillin—Nausea—Cisplatin—bone cancer	0.000186	0.0042	CcSEcCtD
Flucloxacillin—Ill-defined disorder—Epirubicin—bone cancer	0.000182	0.00412	CcSEcCtD
Flucloxacillin—Convulsion—Methotrexate—bone cancer	0.000182	0.00412	CcSEcCtD
Flucloxacillin—Anaemia—Epirubicin—bone cancer	0.000182	0.00411	CcSEcCtD
Flucloxacillin—Arthralgia—Methotrexate—bone cancer	0.000179	0.00404	CcSEcCtD
Flucloxacillin—Myalgia—Methotrexate—bone cancer	0.000179	0.00404	CcSEcCtD
Flucloxacillin—Dysgeusia—Doxorubicin—bone cancer	0.000178	0.00403	CcSEcCtD
Flucloxacillin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000178	0.00402	CcSEcCtD
Flucloxacillin—Malaise—Epirubicin—bone cancer	0.000177	0.00401	CcSEcCtD
Flucloxacillin—Discomfort—Methotrexate—bone cancer	0.000177	0.004	CcSEcCtD
Flucloxacillin—Leukopenia—Epirubicin—bone cancer	0.000176	0.00398	CcSEcCtD
Flucloxacillin—Anaphylactic shock—Methotrexate—bone cancer	0.000171	0.00388	CcSEcCtD
Flucloxacillin—Convulsion—Epirubicin—bone cancer	0.00017	0.00385	CcSEcCtD
Flucloxacillin—Ill-defined disorder—Doxorubicin—bone cancer	0.000169	0.00382	CcSEcCtD
Flucloxacillin—Nervous system disorder—Methotrexate—bone cancer	0.000168	0.0038	CcSEcCtD
Flucloxacillin—Anaemia—Doxorubicin—bone cancer	0.000168	0.0038	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Methotrexate—bone cancer	0.000168	0.0038	CcSEcCtD
Flucloxacillin—Arthralgia—Epirubicin—bone cancer	0.000167	0.00378	CcSEcCtD
Flucloxacillin—Myalgia—Epirubicin—bone cancer	0.000167	0.00378	CcSEcCtD
Flucloxacillin—Skin disorder—Methotrexate—bone cancer	0.000167	0.00377	CcSEcCtD
Flucloxacillin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000166	0.00376	CcSEcCtD
Flucloxacillin—Discomfort—Epirubicin—bone cancer	0.000165	0.00374	CcSEcCtD
Flucloxacillin—Malaise—Doxorubicin—bone cancer	0.000164	0.00371	CcSEcCtD
Flucloxacillin—Leukopenia—Doxorubicin—bone cancer	0.000163	0.00368	CcSEcCtD
Flucloxacillin—Anaphylactic shock—Epirubicin—bone cancer	0.00016	0.00363	CcSEcCtD
Flucloxacillin—Convulsion—Doxorubicin—bone cancer	0.000158	0.00356	CcSEcCtD
Flucloxacillin—Nervous system disorder—Epirubicin—bone cancer	0.000157	0.00356	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Epirubicin—bone cancer	0.000157	0.00355	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000156	0.00353	CcSEcCtD
Flucloxacillin—Skin disorder—Epirubicin—bone cancer	0.000156	0.00352	CcSEcCtD
Flucloxacillin—Myalgia—Doxorubicin—bone cancer	0.000155	0.0035	CcSEcCtD
Flucloxacillin—Arthralgia—Doxorubicin—bone cancer	0.000155	0.0035	CcSEcCtD
Flucloxacillin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000154	0.00348	CcSEcCtD
Flucloxacillin—Discomfort—Doxorubicin—bone cancer	0.000153	0.00346	CcSEcCtD
Flucloxacillin—Dyspepsia—Methotrexate—bone cancer	0.000151	0.00341	CcSEcCtD
Flucloxacillin—Decreased appetite—Methotrexate—bone cancer	0.000149	0.00337	CcSEcCtD
Flucloxacillin—Anaphylactic shock—Doxorubicin—bone cancer	0.000148	0.00336	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Methotrexate—bone cancer	0.000148	0.00335	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000146	0.00331	CcSEcCtD
Flucloxacillin—Nervous system disorder—Doxorubicin—bone cancer	0.000146	0.00329	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Doxorubicin—bone cancer	0.000145	0.00329	CcSEcCtD
Flucloxacillin—Skin disorder—Doxorubicin—bone cancer	0.000144	0.00326	CcSEcCtD
Flucloxacillin—Nafcillin—CYP3A4—bone cancer	0.000143	0.529	CrCbGaD
Flucloxacillin—Feeling abnormal—Methotrexate—bone cancer	0.000141	0.00319	CcSEcCtD
Flucloxacillin—Dyspepsia—Epirubicin—bone cancer	0.000141	0.00319	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Methotrexate—bone cancer	0.00014	0.00317	CcSEcCtD
Flucloxacillin—Decreased appetite—Epirubicin—bone cancer	0.000139	0.00315	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Epirubicin—bone cancer	0.000139	0.00313	CcSEcCtD
Flucloxacillin—Constipation—Epirubicin—bone cancer	0.000137	0.0031	CcSEcCtD
Flucloxacillin—Urticaria—Methotrexate—bone cancer	0.000136	0.00308	CcSEcCtD
Flucloxacillin—Abdominal pain—Methotrexate—bone cancer	0.000136	0.00306	CcSEcCtD
Flucloxacillin—Body temperature increased—Methotrexate—bone cancer	0.000136	0.00306	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000135	0.00306	CcSEcCtD
Flucloxacillin—Feeling abnormal—Epirubicin—bone cancer	0.000132	0.00299	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Epirubicin—bone cancer	0.000131	0.00297	CcSEcCtD
Flucloxacillin—Dyspepsia—Doxorubicin—bone cancer	0.000131	0.00296	CcSEcCtD
Flucloxacillin—Decreased appetite—Doxorubicin—bone cancer	0.000129	0.00292	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000128	0.0029	CcSEcCtD
Flucloxacillin—Dicloxacillin—CYP3A4—bone cancer	0.000128	0.471	CrCbGaD
Flucloxacillin—Urticaria—Epirubicin—bone cancer	0.000127	0.00288	CcSEcCtD
Flucloxacillin—Constipation—Doxorubicin—bone cancer	0.000127	0.00287	CcSEcCtD
Flucloxacillin—Body temperature increased—Epirubicin—bone cancer	0.000127	0.00287	CcSEcCtD
Flucloxacillin—Abdominal pain—Epirubicin—bone cancer	0.000127	0.00287	CcSEcCtD
Flucloxacillin—Hypersensitivity—Methotrexate—bone cancer	0.000126	0.00286	CcSEcCtD
Flucloxacillin—Feeling abnormal—Doxorubicin—bone cancer	0.000122	0.00277	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Doxorubicin—bone cancer	0.000121	0.00275	CcSEcCtD
Flucloxacillin—Hypersensitivity—Epirubicin—bone cancer	0.000118	0.00267	CcSEcCtD
Flucloxacillin—Urticaria—Doxorubicin—bone cancer	0.000118	0.00267	CcSEcCtD
Flucloxacillin—Body temperature increased—Doxorubicin—bone cancer	0.000117	0.00265	CcSEcCtD
Flucloxacillin—Abdominal pain—Doxorubicin—bone cancer	0.000117	0.00265	CcSEcCtD
Flucloxacillin—Diarrhoea—Methotrexate—bone cancer	0.000117	0.00265	CcSEcCtD
Flucloxacillin—Dizziness—Methotrexate—bone cancer	0.000113	0.00256	CcSEcCtD
Flucloxacillin—Diarrhoea—Epirubicin—bone cancer	0.00011	0.00248	CcSEcCtD
Flucloxacillin—Hypersensitivity—Doxorubicin—bone cancer	0.000109	0.00247	CcSEcCtD
Flucloxacillin—Vomiting—Methotrexate—bone cancer	0.000109	0.00247	CcSEcCtD
Flucloxacillin—Rash—Methotrexate—bone cancer	0.000108	0.00244	CcSEcCtD
Flucloxacillin—Dermatitis—Methotrexate—bone cancer	0.000108	0.00244	CcSEcCtD
Flucloxacillin—Headache—Methotrexate—bone cancer	0.000107	0.00243	CcSEcCtD
Flucloxacillin—Dizziness—Epirubicin—bone cancer	0.000106	0.0024	CcSEcCtD
Flucloxacillin—Vomiting—Epirubicin—bone cancer	0.000102	0.00231	CcSEcCtD
Flucloxacillin—Nausea—Methotrexate—bone cancer	0.000102	0.0023	CcSEcCtD
Flucloxacillin—Diarrhoea—Doxorubicin—bone cancer	0.000102	0.0023	CcSEcCtD
Flucloxacillin—Rash—Epirubicin—bone cancer	0.000101	0.00229	CcSEcCtD
Flucloxacillin—Dermatitis—Epirubicin—bone cancer	0.000101	0.00229	CcSEcCtD
Flucloxacillin—Headache—Epirubicin—bone cancer	0.000101	0.00227	CcSEcCtD
Flucloxacillin—Dizziness—Doxorubicin—bone cancer	9.82e-05	0.00222	CcSEcCtD
Flucloxacillin—Nausea—Epirubicin—bone cancer	9.53e-05	0.00216	CcSEcCtD
Flucloxacillin—Vomiting—Doxorubicin—bone cancer	9.44e-05	0.00213	CcSEcCtD
Flucloxacillin—Rash—Doxorubicin—bone cancer	9.36e-05	0.00212	CcSEcCtD
Flucloxacillin—Dermatitis—Doxorubicin—bone cancer	9.35e-05	0.00211	CcSEcCtD
Flucloxacillin—Headache—Doxorubicin—bone cancer	9.3e-05	0.0021	CcSEcCtD
Flucloxacillin—Nausea—Doxorubicin—bone cancer	8.82e-05	0.00199	CcSEcCtD
